McLaren Greater Lansing, part of McLaren Health Care, became the first hospital in the Midwest to perform a vascular surgical procedure for aneurysm repair featuring advanced AI technology. Vascular surgeon and director of the Heart and Vascular Center at MSU Health Care Dr. Jordan Knepper applied Cydar Maps augmented artificial intelligence technology to a Nov. 1 procedure, making him and the McLaren Greater Lansing surgical team one of 20 pilot sites in the United States capable of using the advanced system.
The AI-equipped Cydar Maps surgical platform provides surgeons and clinicians with the ability to create a detailed 3D map personalized to each patient’s unique anatomy for the purpose of planning a procedure and navigating the complexities of their vascular system.
Use of this platform results in a more precise procedure plan in addition to a 50 percent reduction of radiation exposure for both the patient and surgical team while also decreasing pre-operative prep time.
“Cydar Maps is a new technology that brings AI to our operating room, and it helps us more accurately predict where these blood vessels are located,” said Dr. Knepper. “The goal is to use this smart technology to decrease the risk of the patient through the reduction of contrast dye use and radiation exposure as well as minimizing the operating time whilst being under anesthesia.”
Adds Dr. Knepper, “Because of this planning, we’re able to treat more patients, more complex problems, and get in faster and safer with fewer complications.”
The development of this advanced technology resulted from a partnership of Cydar Medical with global medical device leader Medtronic.
“It’s an exciting time in health care to see how the practical application of technology continues to evolve, assisting and further enhancing the capabilities of our skilled providers,” said Dr. Justin Klamerus, McLaren Health Care Executive Vice President and Chief Clinical Officer. “Technology like this means we have the potential to recognize and treat vascular problems with improved accuracy and efficiency. The best result is improved outcomes for our patients.”
The addition of Cydar Maps is the latest in a succession of new technologies McLaren Greater Lansing has added and offered to its patients since moving to its newly constructed hospital in the spring of 2022. Surgical teams have expanded their robotic technology use to advance its orthopedic capabilities — knee and hip joint replacements and spine procedures. The opening of the Izzo Family Medical Center on the hospital’s campus also introduced several imaging units showcasing the latest in diagnostic technology.
Learn more about all of the services offered at McLaren Greater Lansing at mclaren.org/greaterlansing.
About McLaren Greater Lansing
McLaren Greater Lansing, is a tertiary teaching facility with 240 acute care beds, located in Lansing, Michigan on the southern edge of the Michigan State University campus. Among its services are a Level III Trauma Center/Emergency Department, Orthopedic and Sports Medicine Institute, comprehensive cardiac programs, medical/surgical units, and state-of-the-art women and children’s health services including a modern birthing center. Also located at the healthcare campus is the Karmanos Cancer Institute at McLaren Greater Lansing and Outpatient Care Center. Learn more at mclaren.org/greaterlansing.
About McLaren Health Care
McLaren Health Care, headquartered in Grand Blanc, Michigan, is a $6.6 billion, fully integrated health care delivery system committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 14 hospitals in Michigan, ambulatory surgery centers, imaging centers, a 490-member employed primary and specialty care physician network, commercial and Medicaid HMOs covering more than 732,838 lives in Michigan and Indiana, home health, infusion and hospice providers, pharmacy services, a clinical laboratory network and a wholly owned medical malpractice insurance company. McLaren operates Michigan’s largest network of cancer centers and providers, anchored by the Karmanos Cancer Institute, one of only 53 National Cancer Institute-designated comprehensive cancer centers in the U.S. McLaren has 28,000 full-, part-time and contracted employees and more than 113,000 network providers throughout Michigan, Indiana and Ohio. Learn more at mclaren.org.